PL343710A1 - Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine - Google Patents
Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudineInfo
- Publication number
- PL343710A1 PL343710A1 PL99343710A PL34371099A PL343710A1 PL 343710 A1 PL343710 A1 PL 343710A1 PL 99343710 A PL99343710 A PL 99343710A PL 34371099 A PL34371099 A PL 34371099A PL 343710 A1 PL343710 A1 PL 343710A1
- Authority
- PL
- Poland
- Prior art keywords
- abacavir
- lamivudine
- zidovudine
- pharmaceutical compositions
- homogeneous pharmaceutical
- Prior art date
Links
- LHCOVOKZWQYODM-CPEOKENHSA-N 4-amino-1-[(2r,5s)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one;1-[(2r,4s,5s)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1.O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 LHCOVOKZWQYODM-CPEOKENHSA-N 0.000 title 1
- 229960004748 abacavir Drugs 0.000 title 1
- MCGSCOLBFJQGHM-SCZZXKLOSA-N abacavir Chemical compound C=12N=CN([C@H]3C=C[C@@H](CO)C3)C2=NC(N)=NC=1NC1CC1 MCGSCOLBFJQGHM-SCZZXKLOSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9809213.3A GB9809213D0 (en) | 1998-04-29 | 1998-04-29 | Pharmaceutical compositions |
| PCT/EP1999/002794 WO1999055372A1 (en) | 1998-04-29 | 1999-04-26 | Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL343710A1 true PL343710A1 (en) | 2001-08-27 |
Family
ID=10831228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL99343710A PL343710A1 (en) | 1998-04-29 | 1999-04-26 | Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1083932A1 (en) |
| JP (1) | JP2002512979A (en) |
| KR (1) | KR20010043128A (en) |
| CN (1) | CN1411380A (en) |
| AP (1) | AP2000001971A0 (en) |
| AU (1) | AU4135599A (en) |
| BR (1) | BR9910071A (en) |
| CA (1) | CA2330391A1 (en) |
| EA (1) | EA200000997A1 (en) |
| EE (1) | EE200000646A (en) |
| GB (1) | GB9809213D0 (en) |
| HR (1) | HRP20000732A2 (en) |
| HU (1) | HUP0101622A3 (en) |
| ID (1) | ID26955A (en) |
| IL (1) | IL139181A0 (en) |
| IS (1) | IS5675A (en) |
| NO (1) | NO20005418L (en) |
| NZ (1) | NZ507745A (en) |
| PL (1) | PL343710A1 (en) |
| SK (1) | SK16212000A3 (en) |
| TR (1) | TR200003157T2 (en) |
| WO (1) | WO1999055372A1 (en) |
| ZA (1) | ZA200005922B (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6875773B1 (en) | 1998-05-29 | 2005-04-05 | Ben M. Dunn | Combination therapy for treatment of FIV infection |
| CA2374198A1 (en) * | 1998-05-29 | 1999-12-02 | Maki Arai | Combination therapy for treatment of fiv infection |
| GB9820417D0 (en) * | 1998-09-18 | 1998-11-11 | Glaxo Group Ltd | Antiviral combinations |
| US7074417B2 (en) * | 2000-10-13 | 2006-07-11 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-viral product, use and formulation thereof |
| AU2002311622A1 (en) * | 2002-04-23 | 2003-11-10 | Lupin Limited | Long acting compositions comprising zidovudine and lamivudine |
| AR040242A1 (en) * | 2002-06-04 | 2005-03-23 | Glaxo Group Ltd | PHARMACEUTICAL COMPOSITIONS |
| CN100335125C (en) * | 2003-06-03 | 2007-09-05 | 上海现代药物制剂工程研究中心 | Interferon nasal spray powder with long service for detoxication and anti-bacteria |
| WO2006114709A1 (en) * | 2005-04-25 | 2006-11-02 | Aurobindo Pharma Limited | Pharmaceutical compositions of antiretrovirals |
| WO2007013047A2 (en) * | 2005-07-29 | 2007-02-01 | Ranbaxy Laboratories Limited | Water-dispersible anti-retroviral pharmaceutical compositions |
| ES2279707B1 (en) * | 2005-11-10 | 2008-06-01 | Combino Pharm, S.L. | ORAL FORMULATIONS THAT INCLUDE 3'-AZIDONUCLEOSIDS. |
| BRPI0816498A2 (en) * | 2007-10-02 | 2019-02-26 | Emory University | potent combinations of zidovudine and drugs that select for k65r mutation in hiv polymerase |
| US20110117193A1 (en) * | 2008-01-17 | 2011-05-19 | Duquesne University Of The Holy Spirit | Antiretroviral drug formulations for treatment of children exposed to hiv/aids |
| PE20121524A1 (en) * | 2010-01-27 | 2012-12-03 | Viiv Healthcare Co | COMBINATIONS OF COMPOUNDS INCLUDING INHIBITORS OF HIV INTEGRASE AND OTHER THERAPEUTIC AGENTS |
| CN114010776A (en) | 2010-06-09 | 2022-02-08 | 疫苗技术股份有限公司 | Therapeutic immunization of HIV-infected persons for enhancing antiretroviral therapy |
| IN2014MN01907A (en) | 2012-03-05 | 2015-07-10 | Cipla Ltd | |
| CA2885763C (en) | 2012-10-23 | 2021-04-06 | Cipla Limited | Pharmaceutical antiretroviral composition |
| SG10201910773VA (en) | 2013-06-13 | 2020-01-30 | Akebia Therapeutics Inc | Compositions and methods for treating anemia |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY115461A (en) * | 1995-03-30 | 2003-06-30 | Wellcome Found | Synergistic combinations of zidovudine, 1592u89 and 3tc |
| GB9622681D0 (en) * | 1996-10-31 | 1997-01-08 | Glaxo Group Ltd | Pharmaceutical compositions |
-
1998
- 1998-04-29 GB GBGB9809213.3A patent/GB9809213D0/en not_active Ceased
-
1999
- 1999-04-26 HU HU0101622A patent/HUP0101622A3/en unknown
- 1999-04-26 NZ NZ507745A patent/NZ507745A/en unknown
- 1999-04-26 KR KR1020007012021A patent/KR20010043128A/en not_active Withdrawn
- 1999-04-26 HR HR20000732A patent/HRP20000732A2/en not_active Application Discontinuation
- 1999-04-26 BR BR9910071-1A patent/BR9910071A/en not_active IP Right Cessation
- 1999-04-26 JP JP2000545569A patent/JP2002512979A/en active Pending
- 1999-04-26 WO PCT/EP1999/002794 patent/WO1999055372A1/en not_active Ceased
- 1999-04-26 TR TR2000/03157T patent/TR200003157T2/en unknown
- 1999-04-26 SK SK1621-2000A patent/SK16212000A3/en unknown
- 1999-04-26 IL IL13918199A patent/IL139181A0/en unknown
- 1999-04-26 EE EEP200000646A patent/EE200000646A/en unknown
- 1999-04-26 CN CN99807983A patent/CN1411380A/en active Pending
- 1999-04-26 ID IDW20002479A patent/ID26955A/en unknown
- 1999-04-26 AU AU41355/99A patent/AU4135599A/en not_active Abandoned
- 1999-04-26 CA CA002330391A patent/CA2330391A1/en not_active Abandoned
- 1999-04-26 AP APAP/P/2000/001971A patent/AP2000001971A0/en unknown
- 1999-04-26 EP EP99924822A patent/EP1083932A1/en not_active Withdrawn
- 1999-04-26 EA EA200000997A patent/EA200000997A1/en unknown
- 1999-04-26 PL PL99343710A patent/PL343710A1/en unknown
-
2000
- 2000-10-20 IS IS5675A patent/IS5675A/en unknown
- 2000-10-23 ZA ZA200005922A patent/ZA200005922B/en unknown
- 2000-10-27 NO NO20005418A patent/NO20005418L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200005922B (en) | 2001-10-23 |
| JP2002512979A (en) | 2002-05-08 |
| CN1411380A (en) | 2003-04-16 |
| AU4135599A (en) | 1999-11-16 |
| NO20005418L (en) | 2000-11-29 |
| HUP0101622A2 (en) | 2002-03-28 |
| IL139181A0 (en) | 2001-11-25 |
| NO20005418D0 (en) | 2000-10-27 |
| ID26955A (en) | 2001-02-22 |
| AP2000001971A0 (en) | 2000-12-31 |
| GB9809213D0 (en) | 1998-07-01 |
| HUP0101622A3 (en) | 2003-09-29 |
| HRP20000732A2 (en) | 2001-02-28 |
| TR200003157T2 (en) | 2001-01-22 |
| CA2330391A1 (en) | 1999-11-04 |
| IS5675A (en) | 2000-10-20 |
| BR9910071A (en) | 2000-12-26 |
| EP1083932A1 (en) | 2001-03-21 |
| KR20010043128A (en) | 2001-05-25 |
| EA200000997A1 (en) | 2001-06-25 |
| NZ507745A (en) | 2004-07-30 |
| WO1999055372A1 (en) | 1999-11-04 |
| EE200000646A (en) | 2002-04-15 |
| SK16212000A3 (en) | 2001-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9901606D0 (en) | Pharmaceutical compositions | |
| HUP0103507A3 (en) | Pharmaceutical compositions comprising 2-quinolones | |
| CZ20011518A3 (en) | Pharmaceutical preparation | |
| HUP0101622A3 (en) | Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine | |
| GB9827996D0 (en) | Pharmaceutical Compositions | |
| PT1466615E (en) | Pharmaceutical composition | |
| PL343769A1 (en) | Pharmaceutical composition | |
| GB9804469D0 (en) | Antiviral composition | |
| TW385760U (en) | Pen | |
| GB9818591D0 (en) | Pharmaceutical composition | |
| CY2485B1 (en) | Pharmaceutical compositions containing lamivudine and zidovudine. | |
| IL131917A (en) | Pharmaceutical compositions containing lamivudine | |
| HRP20000530B1 (en) | Pharmaceutical compositions | |
| HK1034188A (en) | Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine | |
| AU6085099A (en) | Antiviral combinations comprising lamivudine and abacavir | |
| GB9806487D0 (en) | Pharmaceutical compositions | |
| HU9800078D0 (en) | Pharmaceutical composition | |
| GB9818233D0 (en) | Pharmaceutical composition | |
| HU9801772D0 (en) | Pharmaceutical composition | |
| HK1035865A (en) | Antiviral combinations comprising lamivudine and abacavir | |
| CA84183S (en) | Pen | |
| CA83455S (en) | Pen | |
| TW386492U (en) | Pen structure | |
| GB9827441D0 (en) | Pharmaceutical compositions | |
| GB9826822D0 (en) | Pharmaceutical compositions |